Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia
March 13, 2020Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma
The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …
UK Government criticised for not enacting social distancing measures to combat coronavirus
March 13, 2020Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus
The UK government has come under fire from health experts and former cabinet ministers for its strategy in fighting the …
Keytruda rejected for NHS use for bladder cancer, will be removed from the Cancer Drugs Fund
March 12, 2020Sales and Marketing Cancer, Kidney cancer, MSD, NHS, NICE, blader cancer, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …
Iran foreign ministry accuses US of blocking medicine deliveries
March 12, 2020Business Services Iran, Iran Trump, Trump Iran
A spokesperson from the Iranian foreign ministry has accused the US of refusing to deliver medicine to the country. US …
Trump suspends all travel from Europe to US as coronavirus continues to spread
March 12, 2020Business Services American coronavirus, Chinese Coronavirus, UK Coronavirus, US Coronavirus, Wuhan Coronavirus, wuhan coronavirus.
Last night, President Donald Trump announced significant measures to deal with the increasing threat of the coronavirus. From Friday, the …
Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine
March 12, 2020Sales and Marketing NICE, Teva, ajovy, migraine, pharma
NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …
Bristol-Myers Squibb liver cancer drug combo gets FDA approval
March 12, 2020Business Services Bristol; Myer Squibb, FDA, FDA BSM, FDA approvals
The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …
FDA halts overseas inspections over coronavirus concerns
March 11, 2020Research and Development, Sales and Marketing FDA, US, approvals, pharma
The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …
Ameluz approved by European Commission for treatment for actinic keratosis
March 11, 2020Research and Development EC, EMA, Europe, Lesions
Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …
Takeda’s Ninlaro combo fails to hit main goal in newly diagnosed, transplant ineligible multiple myeloma
March 11, 2020Research and Development, Sales and Marketing Ninlaro, Takeda, multiple myeloma, pharma
Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …
A man from London becomes second person to be cured of HIV
March 11, 2020Research and Development HIV, HIV AIDS, HIV Drug, HIV cure, HIV/AIDS, anti-HIV
Adam Castillejo is the second man to be cured of HIV, after being free of the virus for more than …
Data science firm Genomics Plc names new Chief Strategy Officer
March 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma
Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …
The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns
March 10, 2020Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology
The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …
Boehringer’s TKI inhibitor Ofev gets FDA approval for chronic fibrosing interstitial lung diseases with a progressive phenotype
March 10, 2020Manufacturing and Production, Sales and Marketing Boehringer, FDA, ofev, pharma
The FDA has green-lit Boehringer Ingelheim’s multi-targeted tyrosine kinase inhibitor Ofev (nintedanib) in the treatment of chronic fibrosing interstitial lung …
Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women
March 10, 2020Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin
Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …
Fast-acting mealtime insulin approved for children with diabetes in Canada
March 10, 2020Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes
Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …
Alligator Bioscience hires Chief Financial Officer in interim capacity
March 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alligator Bioscience, pharma
Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it …
Dr Lars Nieba appointed interim Chief Executive Officer at Nordic Nanovector
March 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Nordic Nanovector has appointed Dr Lars Nieba as the interim Chief Executive Officer. He is currently the company’s Chief Technology …
Chris Thatcher to step down as President and CEO of Neuronetics
March 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …
Biogen and Takeda forced to send employees home as coronavirus hits Massachusetts
March 9, 2020Manufacturing and Production, Medical Communications Biogen, Takeda, coronavirus, pharma
Big pharma has been hit by the coronavirus (COVID-19) outbreak right on its doorstep, as two of the biggest names …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
